Login

Theseus Pharmaceuticals, Inc. SEC Filings

Filed On Filing
26 Feb 2024 15-12G
16 Feb 2024 AMENDMENT NO. 3
15 Feb 2024 EFFECT
14 Feb 2024 Form 4: Yi Kathy, Director

Disposed of 3,250 Restricted Stock Units (Disposition to Issuer) · Disposed of 99,634 Stock Option (Right to Buy) (Disposition to Issuer)

14 Feb 2024 Form 4: Stein Steven H, Director

Disposed of 3,250 Restricted Stock Units (Disposition to Issuer)

14 Feb 2024 Form 4: Orbimed Advisors Llc, Director and 2 others

Disposed of 17,713,600 shares (Tender Offer)

14 Feb 2024 Form 4: Hayden Donald J Jr, Director

Disposed of 10,000 shares (Tender Offer) · Disposed of 3,250 Restricted Stock Units (Disposition to Issuer)

14 Feb 2024 Form 4: Gordon Carl L, Director

Disposed of 17,713,600 shares (Tender Offer) · Disposed of 3,250 Restricted Stock Units (Disposition to Issuer)

14 Feb 2024 Form 4: Dukes Iain D., Director

Disposed of 388,324 shares (Tender Offer) · Disposed of 3,250 Restricted Stock Units (Disposition to Issuer) · Disposed of 441,959 Stock Option (Right to Buy) (Disposition to Issuer)

14 Feb 2024 Form 4: Dahms Bradford D., President and CFO

Disposed of 8,150.225 shares (Tender Offer) · Disposed of 17,500 Restricted Stock Units (Disposition to Issuer) · Disposed of 332,114 Stock Option (Right to Buy) (Disposition to Issuer)

14 Feb 2024 S-8 POS
14 Feb 2024 S-8 POS
14 Feb 2024 POS AM
14 Feb 2024 FORM SC TO-T/A
14 Feb 2024 SC 14D9/A
14 Feb 2024 25-NSE
14 Feb 2024 8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +4 more
13 Feb 2024 SC 13G/A
07 Feb 2024 CORRESP
07 Feb 2024 SC 14D9/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support